Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar;19(3):149-150.
doi: 10.1038/d41573-020-00016-0.

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Guangdi Li, Erik De Clercq

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Guangdi Li et al. Nat Rev Drug Discov. 2020 Mar.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. De Clercq, E. & Li, G. Approved antiviral drugs over the past 50 years. Clin. Microbiol. Rev. 29, 695–747 (2016). - PubMed - DOI - PMC
    1. Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S. & Yuen, K. Y. Coronaviruses — drug discovery and therapeutic options. Nat. Rev. Drug Discov. 15, 327–347 (2016). - PubMed - DOI - PMC
    1. Morse, J. S., Lalonde, T., Shiqing, X. & Liu, W. R. Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019‐nCoV. ChemBioChem https://doi.org/10.1002/cbic.202000047 (2020). - DOI
    1. De Clercq, E. New nucleoside analogues for the treatment of hemorrhagic fever virus infections. Chem. Asian J. 14, 3962–3968 (2019). - PubMed - DOI - PMC
    1. Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. https://doi.org/10.1038/s41422-020-0282-0 (2020). - DOI

Publication types

MeSH terms

LinkOut - more resources